A Vasoconstriction Study With LEO 90100

NCT01946386 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis Vulgaris

Interventions

DRUG: LEO 90100 Aerosol, foam
DRUG: Betamethasone dipropionate in LEO 90100 Aerosol, foam, vehicle
DRUG: LEO 90100 Aerosol, foam, vehicle
DRUG: Daivobet® ointment
DRUG: Dermovate® cream
DRUG: Synalar® ointment

Sponsor

LEO Pharma